Skip to search.
 FTSE 100 Down 0.16%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
16.97 Up 0.11(0.65%) 26 Feb 21:00
Add to Portfolio
Prev Close:16.86
Open:16.90
Bid:10.14 x 100
Ask:18.50 x 5700
1y Target Est:25.50
Beta:2.6
Earnings Date:4 May - 8 May (Est.)
Day's Range:16.45 - 17.36
52wk Range:9.39 - 24.69
Volume:530,834
Avg Vol (3m):1,002,780
Market Cap:1.16b
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 0.65%1.16b
AMGNUp 0.56%120.64b
LLYDown 0.47%74.28b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.57
Quarterly EPS Est (Mar-15) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback